Jubilant Draximage (JDI) and Positron have entered an agreement to sourceand supply Strontium-82 and Rubidium-82 generators.
The collaboration is expected to facilitate the stabilization, security and growth of the industry by increasing the supply of radioisotopes and radiopharmaceuticals.
As part of the alliance, Positron will secure a generator supply for future sales of cardiac PET scanners and a customer for Sr-82 while JDI will obtain a supply of Sr-82, a vendor for expired generators management, and a partner with a customer base of cardiac PET scanners installed and serviced.
Jubilant DraxImage President Martyn Coombs said through its wholly owned subsidiary, Manhattan Isotope Technology (MIT), Positron positioned itself as a private entity in the US to serve the Sr82/Rb82 generator lifecycle.
''Their ability to provide a more stable and secure supply of API Sr-82 and management of expired Sr-82/Rb-82 generators fits well with JDI's pre-launch strategy," Coombs added.
Positron CEO Patrick Rooney said JDI has developed Sr82/Rb82 generator and elution system.
''As the Sr82/Rb82 generator on the market has enjoyed tremendous growth and the merits of the technology have been validated many times over, we strongly believe that the arrival of an alternative, upon the FDA clearance of JDI's generator, will be welcomed by the cardiac PET community," Rooney added.
JDI and Positron are expecting to finalise the definitive agreement within 3 months.
